ArticleBMC endocrine disorders2026
Combined residual inflammation and anemia in relation to kidney function among adults with diabetes: a CHARLS-based cross-sectional and longitudinal study.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe combined phenotype of residual inflammation and anemia on kidney function in diabetes remains unclear. Our study examined their joint association with impaired kidney function and kidney function decline in a nationally representative Chinese sample.
methodsOur study encompassed 2,363 diabetes patients from the China Health and Retirement Longitudinal Study (CHARLS) for cross-sectional analysis and a sub-cohort of 547 patients for longitudinal analysis (2011-2015). Exposures comprised residual inflammation (hs-CRP ≥ 2.0 mg/L) and WHO-defined anemia. Outcomes were prevalent impaired kidney function in the cross-sectional analysis and rapid kidney function decline (RKFD) in the longitudinal analysis. Logistic and linear regression, restricted cubic splines, and subgroup and sensitivity analyses were applied.
resultsCross-sectionally, isolated residual inflammation or isolated anemia were each associated with impaired kidney function, while the combined phenotype showed the strongest association (OR = 3.61, 95% CI: 2.16-5.99; P < 0.001). Longitudinally, this combined phenotype conferred the highest risk for RKFD (OR = 6.42, 95% CI: 2.18-18.34; P < 0.001) and was the only group associated with a steeper eGFR decline (β=-8.68 mL/min/1.73 m², 95% CI: -15.72 to -1.64; P = 0.011). Sensitivity analyses and RCS models supported the robustness of these associations.
conclusionCoexisting residual inflammation and anemia are associated with a higher prevalence of kidney function impairment and a more rapid kidney function decline among diabetic patients. Addressing both conditions concurrently as an integrated clinical phenotype may better mitigate kidney function decline. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.